...流动力学异常，表现为高动力循环，即高心输出量，低循环阻力的特点[15]，有学者提出了肝硬化心肌病（Cirrhotic cardiomyopathy）的概念，其发生率约为22-70%[16,17]，此类患者在肝移植围术期心血管并发症发生率高于其他患者，因肝硬化性心肌病加剧肝移植围术期...
基于16个网页-相关网页
为肝硬化心肌病 cirrhotic cardiomyopathy
肝硬化性心肌病 cirrhotic cardiomyopathy
为肝硬化性心肌病 cirrhotic cardiomyopathy
称为肝硬化性心肌病 cirrhotic cardiomyopathy ; CCM
被称为肝硬化性心肌病 cirrhotic cardiomyopathy
结果表明肝硬化存在心肌间质纤维化和肥大细胞浸润，可能参与肝硬化心肌病的发生。
Electromicroscopy pointed to myocardial interstitial fibrosis and MC infiltration, whose presence in cirrhotic myocardium may have played a role in the pathogenesis of cirrhotic cardiomyopathy.
肝硬化性心肌病是肝硬化的并发症之一，主要表现为心脏舒张功能减低、心排血量增加、全身血管阻力降低。
Cirrhotic cardiomyopathy is one of the complications of liver cirrhosis which can be characterized by diastolic dysfunction, high cardiac output and decreased systemic vascular resistance.
肝硬化患者出现心脏结构和功能异常，被称为肝硬化性心肌病。
Cirrhotic cardiomyopathy is the term used to describe a constellation of features indicative of abnormal heart structure and function in patients with cirrhosis.
应用推荐